Torrent Pharmaceuticals Ltd. — Interim / Quarterly Report 2022

Jul 27, 2021

�-torrent- Q PHRRmR

2J[lh] July, 2021

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., I 51 Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 00 I (BSE Scrip Code: 500420)

The Manager - Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5[th ] Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30111 June, 2021

The presentation on unaudited Consolidated Financial Results for the quarter ended 30[1][h ] June, 2021 to be made to analysts is enclosed for your records.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED ��· MAHESH AGRA WAL fi;;;,.[VP (LEGAL) & COMPANY SECRETARY]

Encl: A/a

TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com

==> picture [218 x 79] intentionally omitted <==

Q1 FY 2021-22

Revenues: Summary

==> picture [72 x 54] intentionally omitted <==

1

Revenue: Summar y

==> picture [890 x 10] intentionally omitted <==

Revenues (Rs cr)Q1 FY22Q1 FY21Gr%	Revenues (Rs cr)Q1 FY22Q1 FY21Gr%	Revenues (Rs cr)Q1 FY22Q1 FY21Gr%	Revenues (Rs cr)Q1 FY22Q1 FY21Gr%
India	1,093	925	18%
United States	266	373	-29%
Germany	260	246	5%
Brazil	153	140	9%
Other countries	217	234	-7%
Others (Inc. CRAMS)	146	138	6%
Total	2,134	2,056	4%

==> picture [72 x 54] intentionally omitted <==

2